Pagibaximab
Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. , it is undergoing Phase II/III clinical trials.
≈ 1 min read
Pagibaximab. encyclopegia.org, snapshot enwiki-001187850826. /a/pagibaximab
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. , it is undergoing Phase II/III clinical trials.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1187850826 under CC BY-SA 4.0; modifications have been made.